Parisi Gray Wealth Management Grows Position in Danaher Co. (NYSE:DHR)

Parisi Gray Wealth Management increased its stake in Danaher Co. (NYSE:DHR) by 0.5% during the 4th quarter, Holdings Channel reports. The firm owned 15,749 shares of the conglomerate’s stock after purchasing an additional 73 shares during the quarter. Danaher comprises approximately 1.1% of Parisi Gray Wealth Management’s portfolio, making the stock its 24th biggest holding. Parisi Gray Wealth Management’s holdings in Danaher were worth $3,615,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the stock. Teachers Insurance & Annuity Association of America purchased a new stake in Danaher in the third quarter worth approximately $39,000. MidAtlantic Capital Management Inc. purchased a new position in shares of Danaher during the third quarter worth approximately $40,000. FSA Wealth Management LLC bought a new stake in shares of Danaher in the 3rd quarter worth approximately $50,000. Darwin Wealth Management LLC bought a new position in shares of Danaher during the 3rd quarter valued at $55,000. Finally, Dunhill Financial LLC raised its position in Danaher by 45.1% in the 3rd quarter. Dunhill Financial LLC now owns 222 shares of the conglomerate’s stock worth $62,000 after purchasing an additional 69 shares during the period. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Up 2.0 %

NYSE:DHR traded up $4.76 during trading hours on Monday, reaching $239.83. 3,299,741 shares of the company traded hands, compared to its average volume of 2,915,061. Danaher Co. has a 1 year low of $222.53 and a 1 year high of $281.70. The stock has a market capitalization of $173.22 billion, a P/E ratio of 45.77, a P/E/G ratio of 4.32 and a beta of 0.83. The business’s 50-day moving average price is $235.67 and its two-hundred day moving average price is $253.73. The company has a current ratio of 1.37, a quick ratio of 1.01 and a debt-to-equity ratio of 0.32.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.57 by $0.14. The business had revenue of $5.80 billion during the quarter, compared to analyst estimates of $5.59 billion. Danaher had a net margin of 16.39% and a return on equity of 10.62%. Danaher’s revenue was up 3.1% compared to the same quarter last year. During the same period last year, the business earned $2.02 EPS. Analysts predict that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Friday, December 27th will be paid a dividend of $0.27 per share. The ex-dividend date is Friday, December 27th. This represents a $1.08 annualized dividend and a yield of 0.45%. Danaher’s dividend payout ratio is 20.61%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on DHR. Stifel Nicolaus upped their price target on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. UBS Group reduced their price target on Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research report on Wednesday, October 23rd. KeyCorp increased their price objective on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a research note on Wednesday, October 23rd. Guggenheim initiated coverage on shares of Danaher in a research note on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price on the stock. Finally, Evercore ISI boosted their price target on Danaher from $275.00 to $278.00 and gave the company an “outperform” rating in a report on Tuesday, October 1st. Six analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus target price of $286.80.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.